Impact of SNPs interplay across the locus of MBL2, between MBL and Dectin-1 gene, on women’s risk of developing recurrent vulvovaginal infections

[1]  W. Mendling,et al.  2023 update to 2018 European (IUSTI/WHO) guideline on the management of vaginal discharge. , 2019, International journal of STD & AIDS.

[2]  M. Hosseinzadeh,et al.  Is mannose‐binding lectin serum concentration a reliable predictor for recurrent vulvovaginal candidiasis? , 2019, Mycoses.

[3]  Namarta Kalia,et al.  A Comprehensive in Silico Analysis of Regulatory SNPs of Human CLEC7A Gene and Its Validation as Genotypic and Phenotypic Disease Marker in Recurrent Vulvovaginal Infections , 2018, Front. Cell. Infect. Microbiol..

[4]  A. Sandoval-Carrillo,et al.  Lack of Association between Mannose-binding Lectin 2 Codons 54 and 57 Gene Polymorphisms and Cervicovaginal Infections in Mexican Women , 2017, International journal of biomedical science : IJBS.

[5]  Namarta Kalia,et al.  Genetic and Phenotypic Screening of Mannose-Binding Lectin in Relation to Risk of Recurrent Vulvovaginal Infections in Women of North India: A Prospective Cohort Study , 2017, Front. Microbiol..

[6]  Mi Ae Kim,et al.  Association of MBL With Work-Related Respiratory Symptoms in Bakery Workers , 2016, Allergy, asthma & immunology research.

[7]  Namarta Kalia,et al.  A comprehensive in silico analysis of non-synonymous and regulatory SNPs of human MBL2 gene , 2016, SpringerPlus.

[8]  L. Zhong,et al.  Mannose-binding lectin 2 rs11003123 polymorphism is associated with the development of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis in the Chinese population. , 2016, Hepatobiliary & pancreatic diseases international : HBPD INT.

[9]  Wondemagegn Mulu,et al.  Common causes of vaginal infections and antibiotic susceptibility of aerobic bacterial isolates in women of reproductive age attending at Felegehiwot referral Hospital, Ethiopia: a cross sectional study , 2015, BMC Women's Health.

[10]  L. Singh,et al.  MBL2 Variations and Malaria Susceptibility in Indian Populations , 2013, Infection and Immunity.

[11]  J. Ravel,et al.  Understanding Vulvovaginal Candidiasis Through a Community Genomics Approach , 2013, Current Fungal Infection Reports.

[12]  Yong-Gang Yao,et al.  Genetic variants of complement genes Ficolin-2, Mannose-binding lectin and Complement factor H are associated with leprosy in Han Chinese from Southwest China , 2013, Human Genetics.

[13]  W. Liu,et al.  MBL-Mediated Opsonophagocytosis of Candida albicans by Human Neutrophils Is Coupled with Intracellular Dectin-1-Triggered ROS Production , 2012, PloS one.

[14]  Jacques Ravel,et al.  Vaginal microbiome: rethinking health and disease. , 2012, Annual review of microbiology.

[15]  Krista A. Zanetti,et al.  3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans. , 2012, Cancer research.

[16]  J. Jensen,et al.  European (IUSTI/WHO) guideline on the management of vaginal discharge, 2011 , 2011, International journal of STD & AIDS.

[17]  S. Thiel,et al.  Mannan-binding lectin in women with a history of recurrent vulvovaginal candidiasis. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[18]  S. Tishkoff,et al.  African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. , 2008, Annual review of genomics and human genetics.

[19]  G. Bellen,et al.  Mannose‐binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis , 2008, BJOG : an international journal of obstetrics and gynaecology.

[20]  W. Fetter,et al.  Mannose-binding lectin in term newborns and their mothers: genotypic and phenotypic relationship. , 2008, Human immunology.

[21]  S. Crovella,et al.  ORIGINAL ARTICLE: MBL2 Genetic Screening in Patients with Recurrent Vaginal Infections , 2008, American journal of reproductive immunology.

[22]  M. Christiansen,et al.  The pharmacokinetic profile of plasma-derived mannan-binding lectin in healthy adult volunteers and patients with Staphylococcus aureus septicaemia , 2008, Scandinavian journal of infectious diseases.

[23]  S. Crovella,et al.  The role of mannose-binding lectin gene polymorphisms in women with recurrent bacterial vaginosis. , 2007, American journal of obstetrics and gynecology.

[24]  S. Chanock,et al.  The MBL2 ‘LYQA Secretor’ Haplotype Is an Independent Predictor of Postoperative Myocardial Infarction in Whites Undergoing Coronary Artery Bypass Graft Surgery , 2007, Circulation.

[25]  W. Ledger,et al.  Mannose-Binding Lectin Gene Polymorphism, Vulvovaginal Candidiasis, and Bacterial Vaginosis , 2007, Obstetrics and gynecology.

[26]  Brian Staats,et al.  The mannose-binding lectin (MBL2) haplotype and breast cancer: an association study in African-American and Caucasian women. , 2006, Carcinogenesis.

[27]  K. Kidd,et al.  Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles. , 2006, Human molecular genetics.

[28]  Fei Liu,et al.  Mannose‐binding lectin and vulvovaginal candidiasis , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[29]  S. Chanock,et al.  An analysis of genetic variation across the MBL2 locus in Dutch Caucasians indicates that 3′ haplotypes could modify circulating levels of mannose-binding lectin , 2005, Human Genetics.

[30]  S. Heatley,et al.  Mannose Binding Lectin Acute Phase Activity in Patients with Severe Infection , 2005, Journal of Clinical Immunology.

[31]  Robert B Sim,et al.  Disease-associated Mutations in Human Mannose-binding Lectin Compromise Oligomerization and Activity of the Final Protein* , 2004, Journal of Biological Chemistry.

[32]  M. Christiansen,et al.  Human Plasma‐Derived Mannose‐Binding Lectin: A Phase I Safety and Pharmacokinetic Study , 2004, Scandinavian journal of immunology.

[33]  M. Turner,et al.  The role of mannose-binding lectin in health and disease. , 2003, Molecular immunology.

[34]  W. Ledger,et al.  Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  A. Kok-Jensen,et al.  Mannose-binding lectin polymorphisms in clinical tuberculosis. , 2003, The Journal of infectious diseases.

[36]  H. Valdimarsson.  Infusion of plasma-derived mannan-binding lectin (MBL) into MBL-deficient humans. , 2003, Biochemical Society transactions.

[37]  N. Kaplan,et al.  On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles , 2002, Genetic epidemiology.

[38]  S. Thiel,et al.  Lack of mannose-binding lectin-A enhances survival in a mouse model of acute septic peritonitis. , 2002, Microbes and infection.

[39]  M. Petzl-Erler,et al.  A new strategy for mannose‐binding lectin gene haplotyping , 2002, Human mutation.

[40]  B. Lell,et al.  Promoter variants of the human mannose-binding lectin gene show different binding. , 2000, Biochemical and biophysical research communications.

[41]  B. Høgh,et al.  Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. , 1998, Journal of immunology.

[42]  Stéfansson,et al.  Reconstitution of Opsonizing Activity by Infusion of Mannan‐Binding Lectin (MBL) to MBL‐Deficient Humans , 1998, Scandinavian journal of immunology.

[43]  S. Thiel,et al.  Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. , 1995, Journal of immunology.

[44]  J. Schweinle,et al.  Distinct and overlapping functions of allelic forms of human mannose binding protein , 1992, Nature genetics.

[45]  R. Levinsky,et al.  Molecular basis of opsonic defect in immunodeficient children , 1991, The Lancet.

[46]  Namarta Kalia,et al.  SNPs in 3'-UTR region of MBL2 increases susceptibility to recurrent vulvovaginal infections by altering sMBL levels. , 2019, Immunobiology.

[47]  Namarta Kalia,et al.  Recurrent Vulvovaginal Infections: Etiology, Diagnosis, Treatment and Management , 2018 .

[48]  E. Baracat,et al.  Association between mannose-binding lectin and interleukin-1 receptor antagonist gene polymorphisms and recurrent vulvovaginal candidiasis , 2011, Archives of Gynecology and Obstetrics.

[49]  Gordon D. Brown.  Dectin-1: a signalling non-TLR pattern-recognition receptor , 2006, Nature Reviews Immunology.

[50]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[51]  Namarta Kalia,et al.  Prevalence of Vulvovaginal Infections and Species Specific Distribution of Vulvovaginal Candidiasis in Married Women of North India , 2002 .